期刊文献+

体质量指数对高龄冠心病患者经皮冠状动脉介入术后远期预后的影响分析 被引量:2

Effect of Body Mass Index on Long-term Prognosis of Elderly Patients with Coronary Heart Disease after Percutaneous Poronary Interventio
下载PDF
导出
摘要 【目的】探讨体质量指数(body mass index,BMI)对高龄冠心病患者经皮冠状动脉介入(percutaneous coronary intervention,PCI)术后远期预后的影响。【方法】选择2014年6月至2018年12月在本院诊治的≥60岁稳定型冠心病患者278例,按照BMI分为正常体重组(BMI为18.5~24.0 kg/m2,n=81)、超重组(BMI为24.1~28.0 kg/m2,n=134)、肥胖组(BMI>28.0 kg/m2,n=63),收集入组患者临床资料,分析BMI对患者长期预后的影响。【结果】三组患者在年龄、糖尿病、高血压、高脂血症例数、白细胞(WBC)、血小板(PLT)、血红蛋白(Hb)、高密度脂蛋白胆固醇(HDL-C)及总胆固醇(TC)水平等一般资料比较差异无统计学意义(P<0.05)。正常体重组术后2年死亡率和不良事件发生率分别为8.64%、32.10%,均显著高于超重组2.24%、17.16%和肥胖组的1.59%、11.11%,其差异均有统计学意义(P<0.05)。Logistic回归分析显示:年龄≥70岁、腰围≥90 cm、合并糖尿病、合并高血压、合并高血脂、BMI正常等均为稳定型冠心病患者PCI术后发生不良事件的独立危险因素(P<0.05)。【结论】BMI≥24.0 kg/m2的高龄冠心病患者虽较正常BMI指数患者具有更多的危险因素,但其PCI术后远期预后优于正常BMI患者,且死亡风险较正常BMI患者低。 【Objective】To analyze the effect of body mass index(BMI)on the long-term prognosis of elderly patients with coronary heart disease after percutaneous coronary intervention(PCI).【Methods】From June 2014 to December 2018,278 patients with stable coronary heart disease aged over 60 years were selected and divided into normal weight group(BMI of 18.5-24.0 kg/m2,n=81),overweight group(BMI of 24.1-28.0 kg/m2,n=134)and obesity group(BMI>28.0 kg/m2,n=63)according to BMI.The clinical data of the patients in the admitted were collected to analyze the influence of BMI on the long-term prognosis of patients.【Results】There were no significant differences in age,diabetes mellitus,hypertension,hyperlipidemia,white blood cell(WBC),platelet(PLT),hemoglobin(HB),high density lipoprotein cholesterol(HDL-C)and total cholesterol(TC)levels among the three groups(P<0.05).The 2-year mortality and incidence of adverse events in normal weight group were 8.64%and 32.10%,which were significantly higher than those in overweight group(2.24%,17.16%)and obesity group(1.59%and 11.11%)(P<0.05).Logistic regression analysis showed that age≥70 years,waist circumference≥90 cm,diabetes mellitus,hypertension,hyperlipidemia and normal BMI were independent risk factors for adverse events after PCI in patients with stable coronary heart disease(P<0.05).【Conclusion】Although the elderly patients with coronary heart disease with BMI≥24.0 kg/m2 have more risk factors than those with normal BMI,their long-term prognosis after PCI is better than those with normal BMI,and the risk of death is lower than that of patients with normal BMI.
作者 许茜 吴秋野 朱莉 XU Qian;WU Qiu-ye;ZHU Li(Jiangning Road Street Community Health Service Center,Jing'an District,Shanghai,200040;不详)
出处 《医学临床研究》 CAS 2020年第12期1859-1863,共5页 Journal of Clinical Research
关键词 冠心病 血管成形术 气囊 冠状动脉 人体质量指数 老年人 预后 危险因素 Coronary Disease Angioplasty Balloon Coronary Body Mass Index Aged Prognosis Risk Factors
  • 相关文献

参考文献13

二级参考文献63

  • 1唐晓芳,王婧,袁晋青,杨跃进,乔树宾,刘海波,尤士杰,陈珏,吴元,吴永健,姚民,高润霖.老年冠心病女性患者临床特点及经皮冠状动脉介入治疗疗效分析[J].中华临床医师杂志(电子版),2011,5(21):6239-6243. 被引量:11
  • 2张坚,满青青,王春荣,李红,由悦,翟屹,李莹,赵文华.中国18岁及以上人群血脂水平及分布特征[J].中华预防医学杂志,2005,39(5):302-305. 被引量:112
  • 3张红叶,杨军,周北凡,武阳丰,李莹,陶寿淇.我国十组人群脑卒中危险因素的前瞻性研究[J].中国慢性病预防与控制,1996,4(4):150-152. 被引量:91
  • 4姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 5曹家琪 连志浩 等.队列(群组)研究.流行病学,第2版,第1卷[M].北京:人民卫生出版社,1995.190-206.
  • 6Di Sciascio G, PattiG, Pasceri V, et al. Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary inter- vention: results of the ARMYDA-RECAglXJRE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty)Randomized Trial[J]. J Am Coll Cardiol, 2009,54(6) : 558 - 565.
  • 7Gravning J, Ueland T, Morkrid L, et al. Different prognostic importance of elevated troponin I after percutaneous coronm'y intervention in acute coro- nary syndrome and stable angina peetoris[J]. Scand Cardiovase J,2008,42 (3) :214- 221.
  • 8Patti G, Pascefi V, Colonna G, et al. Atorvastat in pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percu- taneous coronary intervention:resuLts of the ARMYDA-ACS randomized trial [J]. J Am Coil Cardiol,2007,49(12) : 1272 - 1278.
  • 9Ridker PM, MacFadyen JG, Fonseca FA, et al. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high- sensitivity C-reactive protein: justification for the use of statins in preven- Lion: an intervention trial evaluating rosuvastatin(JUPITER)[J]. Circ Car- :liovasc Qual Outcomes,2009,2(6) :616 - 623.
  • 10Mercuro G, Zoncu S, Saiu F, et al. Effect of atorvastatin on endothehum- dependent vasodilation in postmenopausal women with average sennn cholesterol levels[J]. Am J Cardiol,2002,90(7) :747 - 750.

共引文献6811

同被引文献28

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部